ILYANG PHARMACEUTICAL CO.,LTD (일양약품(주))
KOSPI Stock Code: 007570 | DART Corp Code: 00146454
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
| English name (as registered with DART) | ILYANG PHARMACEUTICAL CO.,LTD |
|---|---|
| Korean legal name | 일양약품(주) |
| Alternate names | 일양약품 |
| Market | KOSPI |
| Stock Code | 007570 |
| DART Corp Code | 00146454 |
| CEO | 정유석 |
| Business Registration No. | 2098100872 |
| Corporate Registration No. | 1101110124802 |
| Established Date | 1946-07-01 |
| Fiscal Month | 12 |
| KSIC Industry Code | 212 |
| Address (KO) | 경기도 용인시 기흥구 하갈로 110 |
| Homepage | https://www.ilyang.co.kr/ |
| source_url | https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318000595 |
| verified_at | 2026-11-01T02:19:54.233Z |
Annual Financial Summary (KRW)
Fiscal Year: 2025 | Basis: CFS (Consolidated) | Currency: KRW | Filing Source: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318000595
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 272,422,211,708 | KRW 268,677,532,918 |
| Operating Income (영업이익) | KRW 4,962,569,742 | KRW 9,622,202,657 |
| Net Income (당기순이익) | KRW 7,132,764,228 | KRW 9,282,193,024 |
| Total Assets (자산총계) | KRW 457,330,667,955 | KRW 431,027,453,987 |
| Total Liabilities (부채총계) | KRW 215,922,084,514 | KRW 191,493,987,384 |
| Total Equity (자본총계) | KRW 241,408,583,441 | KRW 239,533,466,603 |
Recent DART Filings (Last 90 Days, up to 20)
| Filed Date | Receipt No. | English Title | Korean Title | Filer |
|---|---|---|---|---|
2026-10-08 | 20261008800172 | [Corrected description]Designation as Unfaithful Disclosure Corporation | [기재정정]불성실공시법인지정 | 유가증권시장본부 |
2026-10-07 | 20261007800786 | Designation as Unfaithful Disclosure Corporation | 불성실공시법인지정 | 유가증권시장본부 |
2026-09-23 | 20260923800619 | Report on Shares Change of Largest Shareholders | 최대주주등소유주식변동신고서 | 일양약품 |
2026-09-23 | 20260923000556 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 정유석 |
2026-09-23 | 20260923000538 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 정도언 |
2026-09-23 | 20260923000533 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 정유석 |
2026-09-23 | 20260923000527 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 정도언 |
2026-09-14 | 20260914000284 | Report on status of specific securities, etc. owned by executives and major shareholders | 임원ㆍ주요주주특정증권등소유상황보고서 | 이제형 |
2026-09-10 | 20260910800601 | Warning on Designation as Unfaithful Disclosure Corporation | 불성실공시법인지정예고 | 유가증권시장본부 |
2026-09-10 | 20260910800099 | [Corrected description]Termination of Single Sales Contract or Supply Contract | [기재정정]단일판매ㆍ공급계약해지 | 일양약품 |
2026-09-09 | 20260909800012 | Termination of Single Sales Contract or Supply Contract | 단일판매ㆍ공급계약해지 | 일양약품 |
2026-08-21 | 20260821000609 | Report on trading plan of specific securities, etc. by executive officers and major shareholders | 임원ㆍ주요주주특정증권등거래계획보고서 | 정유석 |
2026-08-21 | 20260821000603 | Report on trading plan of specific securities, etc. by executive officers and major shareholders | 임원ㆍ주요주주특정증권등거래계획보고서 | 정도언 |
2026-08-14 | 20260814003721 | Semi-annual Report (2026.06) | 반기보고서 (2026.06) | 일양약품 |
Source & Disclaimer
source_url: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318000595 | verified_at: 2026-11-01T02:19:54.233Z
Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.